GlassScriptPhysician profile
Mazyar Rouhani
NPI 1780663492
$7,482.47
in general payments reported to CMS, 2019-2025
15 companies · $5,132 in 2025
The $5,132 reported for 2025 was more than what 98% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $100 · 2022: $376 · 2024: $1,500 · 2025: $5,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,500 · Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,500.00 |
| Food and Beverage | $131.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aidoc Medical LTD | $6,500.00 | 2024-2025 | Briefcase |
| Inari Medical, INC. | $375.72 | 2022 | |
| Radiometer America, INC | $375.00 | 2019 | |
| Portola Pharmaceuticals, LLC | $100.18 | 2020 | |
| Argon Medical Devices, INC. | $58.50 | 2025 | Clot Management |
| Boston Scientific Corporation | $40.12 | 2025 | Watchman Flx |
| Stryker Corporation | $32.95 | 2025 | Flowtriever |
8 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mazyar Rouhani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.